Sri Lanka’s largest pharmaceutical factory aims to meet 25% of local medicine demand

Newswire reports, citing the Ministry of Health, that a pharmaceutical plant in the Bingiriya Investment Zone is nearing completion. The ministry identifies Synergy Pharmaceuticals Corporation Private Limited as its operator and describes it as the country’s largest Western pharmaceutical manufacturing facility.

Newswire says the facility is designed to meet up to 25% of Sri Lanka’s pharmaceutical needs and supply overseas markets. Planned products include tablets, capsules, injectable medicines, cancer treatments and hormonal drugs, with production intended to follow international quality standards.

Newswire reports that Deputy Health Minister Hansaka Wijemuni recently visited the site to review construction, the fitting of modern equipment and progress on a research and development laboratory. The ministry expects the project to increase domestic medicine production and provide opportunities to export locally made products.

Newswire reports that Wijemuni offered government administrative and institutional backing to help complete the remaining work and start commercial operations. The visit also included a discussion of the factory’s longer-term plans, with company management representatives and other officials attending.